AUSTIN, Texas, Oct. 20, 2014 /PRNewswire/ -- On Oct. 16, 2014, surgeons with Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart™ Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., cardiothoracic surgeons at Cardiothoracic and Vascular Surgeons, performed the procedure at Heart Hospital of Austin.
The Solo Smart valve is the first valve with a removable stent to be approved in the U.S. market. Designed from bovine pericardium, the valve is fully biological, with no synthetic material added. This unique prosthesis mimics the healthy native aortic valve, preserves the aortic root physiology, and by eliminating excess synthetic material, maximizes blood flow.
The Solo Smart valve also features a removable nickel-titanium alloy stent, which provides support during implantation, but it is completely removed once the valve is sutured in. Once the stent is removed following implantation, the Solo Smart valve becomes an entirely stentless valve, providing low pressure gradients and large openings.
"We are pleased with the outcome of our first case," Dr. Kerendi said. "The new Solo Smart valve has great potential for patients with valvular heart disease. Its performance is very similar to a native heart valve, and because it requires less suturing time, it can ultimately decrease the amount of time a patient is on a heart-lung-bypass machine."
The Solo Smart Aortic Pericardial Heart Valve was approved by the U.S. Food and Drug Administration in late July 2014. Cardiothoracic and Vascular Surgeons will be training surgeons on how to implant the new valve at Heart Hospital of Austin, which is one of four current training sites across the United States.
Media Contacts:Lisa Candido or Erin OchoaElizabeth Christian & Associates Public Relations512.472.9599
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cardiothoracic-and-vascular-surgeons-in-collaboration-with-heart-hospital-of-austin-first-in-texas-to-implant-solo-smart-aortic-pericardial-heart-valve-699760402.html
SOURCE Heart Hospital of Austin
Advertisement
The Solo Smart valve is the first valve with a removable stent to be approved in the U.S. market. Designed from bovine pericardium, the valve is fully biological, with no synthetic material added. This unique prosthesis mimics the healthy native aortic valve, preserves the aortic root physiology, and by eliminating excess synthetic material, maximizes blood flow.
Advertisement
The Solo Smart valve also features a removable nickel-titanium alloy stent, which provides support during implantation, but it is completely removed once the valve is sutured in. Once the stent is removed following implantation, the Solo Smart valve becomes an entirely stentless valve, providing low pressure gradients and large openings.
"We are pleased with the outcome of our first case," Dr. Kerendi said. "The new Solo Smart valve has great potential for patients with valvular heart disease. Its performance is very similar to a native heart valve, and because it requires less suturing time, it can ultimately decrease the amount of time a patient is on a heart-lung-bypass machine."
The Solo Smart Aortic Pericardial Heart Valve was approved by the U.S. Food and Drug Administration in late July 2014. Cardiothoracic and Vascular Surgeons will be training surgeons on how to implant the new valve at Heart Hospital of Austin, which is one of four current training sites across the United States.
Media Contacts:Lisa Candido or Erin OchoaElizabeth Christian & Associates Public Relations512.472.9599
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cardiothoracic-and-vascular-surgeons-in-collaboration-with-heart-hospital-of-austin-first-in-texas-to-implant-solo-smart-aortic-pericardial-heart-valve-699760402.html
SOURCE Heart Hospital of Austin
